On February 25, Swire Pacific B (00087) spent 1.6083 million Hong Kong dollars to repurchase 150,000 shares.

25/02/2025

GMT Eight

SWIRE PACIFIC B (00087) announced that on February 25, 2025, the company spent 1.6083 million Hong Kong dollars to repurchase 150,000 shares at a repurchase price of 10.66-10.78 Hong Kong dollars per share.

HANSOH PHARMA (03692): HS-10561 Capsules obtained a drug clinical trial approval notice issued by the National Medical Products Administration.

Aojie Technology (688220.SH) reported a net loss of 687 million yuan in 2024, with an expanded loss.

Contact: contact@gmteight.com

On February 25, Swire Pacific B (00087) spent 1.6083 million Hong Kong dollars to repurchase 150,000 shares.

RECOMMEND

BIOSTAR PHARM-B (02563) included in Hang Seng Composite Index constituents.

Chinese technology stocks may have stopped falling? Overseas institutions: the pullback brings a good buying opportunity.

Hong Kong Land Department: SHK PPT (00016) successfully bid for the Sha Tin land for 606 million Hong Kong dollars.